Bictegravir/emtricitabine/tenofovir alafenamide
Bictegravir/emtricitabine/tenofovir alafenamide was ranked 1654th of 1,796 medicines by items in May 2026, with 3 items, down 40.0% on a year earlier.
Dispensed in May 2026
Rolling 12 months
Net ingredient cost · May 2026
Figure 1. Bictegravir/emtricitabine/tenofovir alafenamide: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2026
Embed this chart
Free to reuse with the credit line above.
At a glance
- Therapeutic class Antiviral drugs
- Presentations 1 shown
- Average cost / item £879.51
- Year on year Down 40.0% on a year earlier
Top presentations, May 2026
The individual products dispensed under Bictegravir/emtricitabine/tenofovir alafenamide this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Biktarvy 50mg/200mg/25mg tablets | 0503010AQBBAAAA | 3 | £2,639 |
Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0
Where Bictegravir/emtricitabine/tenofovir alafenamide is dispensed
The regions and dispensing practices with the highest Bictegravir/emtricitabine/tenofovir alafenamide volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Bictegravir/emtricitabine/tenofovir alafenamide with
Other medicines in the same BNF section, by prescribing volume.
Download this data
The monthly series for Bictegravir/emtricitabine/tenofovir alafenamide is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.